| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |